Matthew Angel, CEO and President: Tempest Therapeutics TPST Buy · Filed 06/23

Trade details

Type: Insider buy
Amount: $500,001.12
Shares · price: 231,482 sh · $2.16 a share
Held after: 231,482 sh
Stock: Tempest Therapeutics TPST
Person: Matthew AngelCEO and President
Trade date: 26/03/24
Filed: 26/06/23
Days to filing: 91 days

First buy since 2023

Insiders buying this week: 1 insiders

Tempest Therapeutics trades, last 26 weeks

What else happened in Tempest Therapeutics around then

Filed or reported within 30 days of the trade day · 02/22~04/23

Matthew Angel's recent trades

Matthew AngelCEO and President
BuyTempest Therapeutics
Buy
Tempest Therapeutics
TPST
$500K
231,482 sh
$500K
Filed 03/25
Traded 03/24